Skip to main content
Home
Home
  • Register here
  • Sign In
  • Home
  • News Feed
  • Therapeutic areas
    • Cardio-Metabolic
      • Heart Failures
      • Dyslipidemia
    • Dermatology
      • Psoriasis (PsO)
    • Rheumatology
      • Spondyloarthritis
    • Ophthalmology
      • Ophthalmology
    • Respiratory
      • BLOCK IgE; UNLOCK LIFE in 3 indications
      • IgE-Related Chronic Diseases
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Melanoma
      • Oncology Publication
    • Hematology
      • CML
      • ITP
      • MPN
      • SAA
    • Transplant
      • Transplant
    • Neurology
      • Dementia
    • Rare Disease
      • Spinal Muscular Atrophy (SMA)
  • Exclusive event
  • Pharma Corner

Popular Search

  • heart
  • heart failure
  • medical
  • medical information/c
  • dme

Recent News

IgE-Related Chronic Diseases TISTOK
LIPID Management and CVD Forum 2024
PEAK 2024 (SAA & MPN)
Search
  1. VDO test

https://www.kaltura.com/index.php/extwidget/preview/partner_id/2076321/uiconf_id/46737343/entry_id/1_5xrpv9k9/embed/iframe?

×

Medical Information Request

×

Ask Speakers

Latest Content

Pharma Corner

PEAK 2024 (Heart Failure)

Pharmacy Education and Knowledge //--> 26 min 02 sec Expanding the Role of ARNI: Essential Treatment for Heart Failure and Hypertension Management - Does Quality Matter?

Ph.Krittin Bunditanukul Pharm.D, F.A.C.P, BCPS., Chulalongkorn University

Home Show More

Print
Pharma Corner

PEAK 2024

Print
Dyslipidemia

LIPID Management and CVD Forum 2024

LIPID Management and CVD Forum //--> 20 min 26 sec Practical Points from New 2024 RCPT Guideline for Dyslipidemia Management

Prof. Thananya Boonyasirinant, M.D. Cardiologist, Siriraj Hospital

//--> 30 min 55 sec Lipid Registry Updated //--> 20 min 58 sec Lipoprotein(a): Hidden Culprit in Cardiovascular Disease

Prof. Weerapan Khovidhunkit, M.D. Ph.DShow More

Print
Oncology

Lung Cancer Publication

RTE_What is CHI? DownloadShow More
Print
Educational

Ribociclib AE management in QT Prolongation

Ribociclib AE management in QT ProlongationShow More
Print
Educational

Ribociclib AE management in Neutropenia

Ribociclib AE management in NeutropeniaShow More
Print
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
 of  38
Sitemap
©2025 Novartis Pharma
  • Terms of use
  • Privacy
The site is intended for HCP local audiences